Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synovial membranes

Journal of Rheumatology

Volumn 38, Issue 2, 2011, Pages 339-349

  Hermida Gómez, Tamara ^a   Fuentes Boquete, Isaac ^a   Gimeno Longas, Maria José ^a   Muiños López, Emma ^a   Díaz Prado, Silvia ^a   De Toro, Francisco Javier ^a   Blanco, Francisco Javier ^a  

^a UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Cartilage; Mesenchymal Stem Cell; Osteoarthritis; Synovium

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BETA1 INTEGRIN; CALCIUM; CD34 ANTIGEN; CD45 ANTIGEN; CELL MARKER; COLLAGEN TYPE 2; ENDOGLIN; HERMES ANTIGEN; LIPID; PROTEIN; PROTEIN STRO 1; PROTEOGLYCAN; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BONE DEVELOPMENT; CHONDROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN TISSUE; MESENCHYMAL STEM CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIUM;

AGED; ANTIGENS, CD; BIOLOGICAL MARKERS; CARTILAGE; CELLS, CULTURED; CHONDROGENESIS; FEMALE; FLOW CYTOMETRY; HUMANS; JOINTS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 79551690949     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.100614     Document Type: Article

References (20)

1. Brandt KD, Mazzuca SA. Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: the doxycycline trial. Rheum Dis Clin North Am 2006;32:217-34.
2. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. Arthritis Rheum 2004;50:1522-32. (Pubitemid 38608074)
3. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, Evans DJ, et al. The surface of articular cartilage contains a progenitor cell population. J Cell Sci 2004;117:889-97.
4. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-7.
5. Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-5.
6. Djouad F, Bony C, Häupl T, Uze G, Lahlou N, Louis-Plence P, et al. Transcriptional profiles discriminate bone marrow-derived and synovium-derived mesenchymal cells. Arthritis Res Ther 2005;7:R1304-15.
7. De Bari C, Dell'Acio F, Tylzanowski P, Luyten FP. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001;44:1928-42. (Pubitemid 32758241)
8. Fickert S, Fiedler J, Brenner RE. Identification, quantification and isolation of mesenchymal progenitor cells from osteoarthritic synovium by fluorescence automated cell sorting. Osteoarthritis Cartilage 2003;11:790-800.
9. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum 2005;52:2521-9.
10. Shirasawa S, Sekiya I, Sakaguchi Y, Yagishita K, Ichinose S, Muneta T. In vitro chondrogenesis of human synovium-derived mesenchymal stem cells: Optimal condition and comparison with bone marrow-derived cells. J Cell Biochem 2006;97:84-97.
11. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. et al. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 1998;238:265-72.
12. Lee RH, Kim B, Choi I, Kim H, Choi HS, Suh K, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 2004;14:311-24. (Pubitemid 39179200)
13. Majumdar MK, Banks V, Peluso DP, Morris EA. Isolation, characterization, and chondrogenic potential of human bone marrow-derived multipotential stromal cells. J Cell Physiol 2000;185:98-106.
14. Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, et al. Isolation and characterization of bone marrow multipotential mesenchymal progenitors cells. Arthritis Rheum 2002;46:3349-60.
15. Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004;50:817-27.
16. Richler C, Yaffe D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev Biol 1970;23:1-22.
17. Fuentes-Boquete I, López-Armada MJ, Maneiro E, Fernández-Sueiro JL, Caramés B, Galdo F, et al. Pig chondrocyte xenoimplants for human chondral defect repair: an in vitro model. Wound Repair Regen 2004;12:444-52. (Pubitemid 39007045)
18. Vandenabeele F, De Bari C, Moreels M, Lambrichts I, Dell'Accio F, Lippens PL, et al. Morphological and immunocytochemical characterization of cultured fibroblast-like cells derived from adult human synovial membrane. Arch Histol Cytol 2003;66:145-53.
19. Barry F, Boynton R, Murphy M, Haynesworth S, Zaia J. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 2001;289:519-24. Erratum in: Biochem Biophys Res Commun 2002;290:1609.
20. Hunziker EB, Rosenberg LC. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am 1996;78:721-33.